Home/Filings/4/0001179110-17-015257
4//SEC Filing

Arnson Eric R 4

Accession 0001179110-17-015257

CIK 0001651561other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 4:57 PM ET

Size

12.3 KB

Accession

0001179110-17-015257

Insider Transaction Report

Form 4
Period: 2017-12-08
Arnson Eric R
10% Owner
Transactions
  • Sale

    Common Stock

    2017-12-08$25.85/sh523,805$13,540,3591,390,273 total(indirect: By: Originate Growth Fund #1Q, L.P.)
  • Sale

    Common Stock

    2017-12-08$25.85/sh237,195$6,131,491629,594 total(indirect: By: Originate Growth Fund #1A, L.P.)
  • Sale

    Common Stock

    2017-12-11$25.85/sh72,625$1,877,356556,969 total(indirect: By: Originate Growth Fund #1A, L.P.)
  • Sale

    Common Stock

    2017-12-11$25.85/sh160,375$4,145,6941,229,898 total(indirect: By: Originate Growth Fund #1Q, L.P.)
Holdings
  • Common Stock

    (indirect: By Spouse)
    7,500
Footnotes (6)
  • [F1]Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
  • [F2]Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
  • [F3]Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
  • [F4]Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
  • [F5]The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Arnson disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.
  • [F6]Represents shares held by Mr. Arnson's wife. Mr. Arnson disclaims beneficial ownership of such shares. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis.

Issuer

Tabula Rasa HealthCare, Inc.

CIK 0001651561

Entity typeother

Related Parties

1
  • filerCIK 0001685942

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:57 PM ET
Size
12.3 KB